Kiniksa Pharmaceuticals International, plc Deferred Tax Assets, Operating Loss Carryforwards
Kiniksa Pharmaceuticals International, plc (KNSA) had Deferred Tax Assets, Operating Loss Carryforwards of $109.36 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-24
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $109.36M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $85.37M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.13M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $4.05M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $109.36M 10-K · filed 2026-02-24 |
| 2024-12-31 | $85.37M 10-K · filed 2026-02-24 |
| 2023-12-31 | $1.13M 10-K · filed 2025-02-25 |
| 2022-12-31 | $4.05M 10-K · filed 2024-02-28 |
| 2021-12-31 | $8.56M 10-K · filed 2023-03-02 |
| 2020-12-31 | $198.00K 10-K · filed 2022-02-24 |
| 2019-12-31 | $190.00K 10-K · filed 2021-02-25 |